Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
|
|
31.
|
|
|
32.
|
|
|
33.
|
|
|
34.
|
|
|
35.
|
|
|
36.
|
|
|
37.
|
Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapy. [electronic resource] by
- Lin, P F
- Samanta, H
- Rose, R E
- Patick, A K
- Trimble, J
- Bechtold, C M
- Revie, D R
- Khan, N C
- Federici, M E
- Li, H
Producer: 19941201
In:
The Journal of infectious diseases vol. 170
Availability: No items available.
|
|
38.
|
Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor. [electronic resource] by
- Lin, P F
- Samanta, H
- Bechtold, C M
- Deminie, C A
- Patick, A K
- Alam, M
- Riccardi, K
- Rose, R E
- White, R J
- Colonno, R J
Producer: 19970123
In:
Antimicrobial agents and chemotherapy vol. 40
Availability: No items available.
|
|
39.
|
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine. [electronic resource] by
- Tenney, D J
- Levine, S M
- Rose, R E
- Walsh, A W
- Weinheimer, S P
- Discotto, L
- Plym, M
- Pokornowski, K
- Yu, C F
- Angus, P
- Ayres, A
- Bartholomeusz, A
- Sievert, W
- Thompson, G
- Warner, N
- Locarnini, S
- Colonno, R J
Producer: 20041018
In:
Antimicrobial agents and chemotherapy vol. 48
Availability: No items available.
|